{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:55:23Z","timestamp":1761173723699,"version":"build-2065373602"},"reference-count":2,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.purol.2020.10.006","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T09:15:10Z","timestamp":1605863710000},"page":"145-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Faut il encore proposer la toxine botulique en premi\u00e8re intention chez les patients porteurs d\u2019une hyperactivit\u00e9 de vessie idopathique\u00a0? Commentaire \u00e0\u00a0: efficacit\u00e9 et tol\u00e9rance \u00e0 long terme des injections d\u2019abobotulinumtoxinA dans le traitement de l\u2019hyperactivit\u00e9 v\u00e9sicale idiopathique"],"prefix":"10.1016","volume":"31","author":[{"given":"A.","family":"Ruffion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2020.10.006_bib0015","article-title":"Sacral Neuromodulation with the InterStim (System forIntractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of ClinicalEffectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study","author":"Chartier-Kastler","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.purol.2020.10.006_bib0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/JU.0000000000000656","article-title":"Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: results of the ROSETTA Randomized Trial","volume":"203","author":"Harvie","year":"2020","journal-title":"J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708720306746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708720306746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:34:17Z","timestamp":1761114857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708720306746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":2,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1166708720306746"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2020.10.006","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faut il encore proposer la toxine botulique en premi\u00e8re intention chez les patients porteurs d\u2019une hyperactivit\u00e9 de vessie idopathique\u00a0? Commentaire \u00e0\u00a0: efficacit\u00e9 et tol\u00e9rance \u00e0 long terme des injections d\u2019abobotulinumtoxinA dans le traitement de l\u2019hyperactivit\u00e9 v\u00e9sicale idiopathique","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2020.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2020.07.242","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}